Effects of Sacubitril/Valsartan on Subclinical Heart Failure in HIV (The ENCHANTMENT HIV Study)
Condition(s):HIV/AIDS; Heart Failure With Preserved Ejection FractionLast Updated:November 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):HIV/AIDS; Heart Failure With Preserved Ejection FractionLast Updated:November 13, 2023Recruiting
Condition(s):Bioequivalence StudyLast Updated:February 22, 2024Not yet recruiting
Condition(s):Obesity; Cardiovascular Diseases; Hypertension; Nocturnal Blood Pressure; Natriuretic Peptides; Renin-Angiotensin-Aldosterone SystemLast Updated:March 7, 2024Recruiting
Condition(s):Myocardial Infarction; HypertensionLast Updated:September 29, 2021Unknown status
Condition(s):Heart Failure With Preserved Ejection FractionLast Updated:February 4, 2022Completed
Condition(s):Heart FailureLast Updated:August 26, 2021Completed
Condition(s):Heart FailureLast Updated:October 7, 2021Completed
Condition(s):Heart Failure NYHA Class IV; Heart Failure NYHA Class IILast Updated:February 1, 2021Completed
Condition(s):Heart Failure, Reduced Ejection FractionLast Updated:October 7, 2021Completed
Condition(s):Heart Failure With Preserved Ejection Fraction (HFpEF)Last Updated:February 21, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.